STEPHANIE CARSON: Open Payments
NPI 1609379288 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 83 payments from 41 companies in 2025. Trend: 2023 $1,542 · 2024 $2,010 · 2025 $2,131
Food & beverage: $2,068Honoraria: $63
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $210 |
| Kite Pharma, Inc. | 1 | $144 |
| Novartis Pharmaceuticals Corporation | 5 | $140 |
| Lilly USA, LLC | 4 | $103 |
| Daiichi Sankyo Inc. | 4 | $102 |
| PFIZER INC. | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
| PharmaEssentia USA Corporation | 2 | $64 |
| Genentech USA, Inc. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
Products named: KEYTRUDA, Yescarta, VERZENIO, SCEMBLIX, BESREMI, OPDIVO, ZEPZELCA, Orserdu.
Industry payments across SC — which companies pay providers there.
